Pulmonology

1. In this prospective cohort study, patients with symptomatic pulmonary embolism (PE) and a patent foramen ovale (PFO) were found to have a significantly...

Tuberculosis (TB) is the leading cause of death by an infectious disease. Identifying affected individuals, particularly if they are asymptomatic, however, remains a challenge...

Understanding the burden of health conditions in older adults in the U.S. is essential in addressing the healthcare demands of this patient population. This...

1. In this direct observational study, first year internal medicine residents (interns) spent only 13% of their time on direct patient care, while spending...

1. A randomized control trial of adult ICU patients randomized to receive either adjunct intermittent pneumatic compression with pharmacologic thromboprophylaxis versus pharmacologic thromboprophylaxis only...

Pembrolizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1). Previous studies have shown that pembrolizumab is effective in prolonging survival in...

1. In patients with non-small cell lung cancer (NSCLC), an analysis of clinical and genomic data from routine care replicated previously established relationships between...

Malignant pleural mesothelioma is a devastating cancer, with survival rates ranging from as low as 17% to 46%. Diagnosis and/or treatment usually involves an...

1. A G551D missense mutation in the cystic fibrosis transmembrane conductance receptor (CFTR) is a genetic cause of cystic fibrosis (CF).2. In utero administration...

1. A randomized control trial of patients with multidrug resistant tuberculosis found that shorter treatment regimens were noninferior to longer treatment regimens currently recommended...